ENA0000GenomicsMultiomicsALLEN, Penn State Hershey Medical Ctrhttps://www.ebi.ac.uk/ena/browser/view/PRJNA149831Homo sapiensTIC10-induced transcriptional changes at 48hrs in HCT116 p53-null cells (10uM). Overall design: Six samples of HCT116 p53-null cells with TIC10 (10uM) or DMSO treatment. Three replicates each.ENAPRKBA, DmErk, extracellular signal-regulated kinase activity, Akt/PKB, pp44mapk, Tyro5, DAKT1/PKB, Mpk2, Apo-2L, p42mapk, D-p38, TNFSF10, AKT1, FOXO3A, p38 alpha, p38a, SR2-1, LeMPK3, P44ERK1, FoxO3A, p44mpk, Dp38, mitogen-activated protein kinase activity, SAPK2, mpk2, SEM, Sem, mpk1, p38A, MAP-k, C76856, Erk/Map kinase, pp42, EK5, DERK-A, Dsor2, E(sina)7, sem, Rl, PKB|Akt, RacPK, MP kinase activity, DERK, Dmp38a, MBP kinase II activity, ATP - protein phosphotransferase (MAPKK-activated) activity, dERK, CG5475, TL, DmMPK2, PKB alpha, ERK-A, protein TRAIL, MNK1, Mnk1, MAP kinase 2 activity, dpERK, dpErk, dakt, apo-2 ligand, Mapk, ERK-1, ERK-2, Erk1, ERK1, ERK2, mapk1a, DmMAPK, Erk2, RAC-PK-alpha, PMK-2, l(3)89Bq, dp-ERK, PMK-1, D-P38a, PMK-3, AKT1 kinase, D-p38a, PKB/Akt, PKB/AKT, AKT/PKB, protein kinase B alpha, p41mapk, dAkt, dAKT, MapK, mapk1b, MAPK, pMAPK, pMapK, p-Akt, P38, D-MPK2, 2010203A17Rik, DAkt, erk2, TL2, mapk, l(3)04226, AF6q21, DmelCG5475, DPKB, ERKa, apo-2L, Tumor., DmERKA, rl/MAPK, BcDNA:RE08694, pAkt, l(2R)EMS45-39, CAPB, DmelCG12559, p38, l(2)41Ac, INSDC_feature:gene, proto-oncogene c-Akt, Mtap2k, dAKT/dPKB, PKB/dAKT, protein kinase B, C78273, DpErk, DpERK, ErkA, ERKA, HUMKER1A, CT34260, Dakt, dpERk, p41, dPKB, p40, SAPK, P44MAPK, p44, pERK, RAC-ALPHA, 9030612K14Rik, p44erk1, DRAC-PK85, D-p38 MAPK, DmelCG4006, GroupII, 12559, EK2-1, Dpkb, TRAIL, dp38a, Hek5, HS44KDAP, AA407128, dMPK2, Prkm1, Prkm3, p42-MAPK, ERK, Erk, PRKM1, PRKM3, PRKM2, p38Ka, FOXO2, xp42, PCBC, p42 mitogen-activated protein kinase activity, CG18732, ATP:protein phosphotransferase (MAPKK-activated) activity, erk, Erk-1, AKT, Akt, Fkhr2, DRAC-PK, rll, DmERK-A, STK26, p38-2, myelin basic protein kinase activity, CD253, Dp38a, FKHRL1, ert1, DRT, Esrk1, akt, DMPK2, stress-activated kinase activity, prkm2, CT39192, prkm1, MAP-2 kinase activity, DAkt1, DAKT1, FKHRL1P2, p38delta, PKB, CWS6, group 2, stress-activated protein kinase activity, mapk2, PKB-ALPHA, mapk1, MBP kinase I activity, D-Akt, CG4006, Fkhrl1, Xp42, Dakt1, serine-threonine kinase Akt, CG12559, akt1, dAkt1, mitogen activated kinase activity, Su(Raf)2B, P42MAPK, DRAC-PK66, dpERK1, EY2-2, MAPK2, MAPK1, TNF-related apoptosis-inducing ligand, dp38, APO2L, dAkt/PKB, dakt1, AU018647, D-ERK, dpMAPK, Foxo3a, Ert2, ERT1, ERT2, PKBalpha, EPHT3, p44-MAPK, p44-ERK1, dAKT1, Rac, RAC, 1110048B16Rik, p44mapk, SAP kinase activity, MAP kinase 1 activity, thymoma viral proto-oncogenehuman being, human., man0.00.00.00.00.00falseHomo sapiensDual inactivation of Akt and ERK by small molecule TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction and potent anti-tumor effects2022-05-122014-02-11PRJNA149831GSE34194233902479606